Temasek Holdings (Private) Ltd - PORTOLA PHARMACEUTICALS INC ownership

PORTOLA PHARMACEUTICALS INC's ticker is PTLA and the CUSIP is 737010108. A total of 204 filers reported holding PORTOLA PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.

Quarter-by-quarter ownership
Temasek Holdings (Private) Ltd ownership history of PORTOLA PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2020$34,177,000
-70.1%
4,793,3760.0%0.25%
-66.4%
Q4 2019$114,466,000
-17.5%
4,793,376
-7.4%
0.75%
-26.4%
Q3 2019$138,771,000
-1.1%
5,174,1680.0%1.02%
+1.4%
Q2 2019$140,375,000
-21.8%
5,174,1680.0%1.00%
-19.3%
Q1 2019$179,544,000
+77.8%
5,174,1680.0%1.24%
+78.8%
Q4 2018$101,000,000
-26.7%
5,174,1680.0%0.70%
-13.3%
Q3 2018$137,788,000
-29.5%
5,174,1680.0%0.80%
-21.9%
Q2 2018$195,428,000
+22.5%
5,174,168
+6.0%
1.03%
+17.4%
Q1 2018$159,497,000
-32.9%
4,883,5680.0%0.88%
-40.1%
Q4 2017$237,732,000
-9.9%
4,883,5680.0%1.46%
-4.9%
Q3 2017$263,859,000
-3.8%
4,883,5680.0%1.54%
-13.1%
Q2 2017$274,310,000
+6.3%
4,883,568
-25.8%
1.77%
-8.1%
Q1 2017$258,010,000
+74.6%
6,583,5680.0%1.92%
+62.8%
Q4 2016$147,735,000
-1.2%
6,583,5680.0%1.18%
-2.4%
Q3 2016$149,513,000
-3.8%
6,583,5680.0%1.21%
-0.2%
Q2 2016$155,372,000
+15.7%
6,583,5680.0%1.21%
+14.7%
Q1 2016$134,305,000
-60.3%
6,583,5680.0%1.06%
-58.9%
Q4 2015$338,725,000
+36.2%
6,583,568
+12.9%
2.57%
+9.0%
Q3 2015$248,627,000
-6.4%
5,833,5680.0%2.36%
+42.1%
Q2 2015$265,719,000
+20.0%
5,833,5680.0%1.66%
+0.1%
Q1 2015$221,442,000
+34.0%
5,833,5680.0%1.66%
-3.4%
Q4 2014$165,207,000
+54.4%
5,833,568
+37.8%
1.72%
+50.9%
Q3 2014$107,025,000
-13.4%
4,233,5680.0%1.14%
-38.5%
Q2 2014$123,536,000
+12.7%
4,233,5680.0%1.85%
+8.9%
Q1 2014$109,649,000
+0.6%
4,233,5680.0%1.70%
-24.6%
Q4 2013$109,014,000
-3.7%
4,233,5680.0%2.26%
-27.9%
Q3 2013$113,248,000
+8.9%
4,233,5680.0%3.13%
+18.8%
Q2 2013$104,019,0004,233,5682.64%
Other shareholders
PORTOLA PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
IFP Advisors, Inc 0$00.00%
View complete list of PORTOLA PHARMACEUTICALS INC shareholders